McDonald R, Thakkar B, Wolfe L G, Deinhardt F
Int J Cancer. 1976 Mar 15;17(3):396-406. doi: 10.1002/ijc.2910170317.
Two strains of feline fibrosarcoma virus (ST-FeSV and GA-FeSV) were found to induce tumors in cats and marmosets, and to transform feline and marmoset cells in vitro after primary inoculation. A third strain (SM-FeSV) failed to induce tumors or transform marmoset cells after primary inoculation; however, when SM-FeSV-injected marmoset cultures were passed 26 times in vitro, the cell cultures released infectious virus which transformed marmoset fibroblasts but still failed to induce tumors in marmosets. ST-FeSV induced mainly round-cell type transformation (r foci), GA-FeSV induced predominantly mixed round-fusiform cell type transformation (fr foci), and SM-FeSV induced r and fr type foci with a higher proportion of fusiform cells in the fr foci than seen with GA-FeSV. Transforming virus was obtained from r or mixed r/fr foci of ST-FeSV but not from fr foci; heat treatment changed the virus from producing almost exclusively r type foci to inducing an increased number of fr foci. Passage of FeSV in cat cells yielded viruses with a higher ratio of infectivity for feline vs marmoset cells, while passage of FeSV in marmoset cells yielded virus with a relatively higher infectivity ratio for marmoset cells; the three strains differed in the degree of change in the infectivity ratio. Despite the alteration of host range of SM-FeSV propagated in marmoset fibroblasts, the virus retained feline P-30 antigen by CF and FA assays. Neutralization tests did not indicate but also did not exclude an alteration of the surface antigens of ST-FeSV or SM-FeSV propagated in marmoset fibroblasts. The alteration of the relative infectivity of FeSV during passage in marmoset cells may be due to: (1) the selection of a variant present in the original heterogenous uncloned population; (2) mutation; or (3) recombination with some marmoset genetic material, possibly an as yet unidentified endogenous marmoset virus.
发现两株猫纤维肉瘤病毒(ST - FeSV和GA - FeSV)可在猫和狨猴体内诱发肿瘤,并在初次接种后于体外转化猫和狨猴细胞。第三株病毒(SM - FeSV)在初次接种后未能诱发肿瘤或转化狨猴细胞;然而,当注射了SM - FeSV的狨猴培养物在体外传代26次后,细胞培养物释放出传染性病毒,该病毒可转化狨猴成纤维细胞,但仍无法在狨猴体内诱发肿瘤。ST - FeSV主要诱导圆形细胞型转化(r灶),GA - FeSV主要诱导混合圆形 - 梭形细胞型转化(fr灶),而SM - FeSV诱导r和fr型灶,且fr灶中梭形细胞的比例高于GA - FeSV。转化病毒可从ST - FeSV的r或混合r/fr灶中获得,但不能从fr灶中获得;热处理使病毒从几乎只产生r型灶转变为诱导更多数量的fr灶。FeSV在猫细胞中传代产生的病毒对猫细胞与狨猴细胞的感染性比值更高,而FeSV在狨猴细胞中传代产生的病毒对狨猴细胞的感染性比值相对更高;这三株病毒在感染性比值变化程度上存在差异。尽管在狨猴成纤维细胞中传代的SM - FeSV宿主范围发生了改变,但通过补体结合试验(CF)和荧光抗体试验(FA)检测发现该病毒仍保留猫P - 30抗原。中和试验既未表明也未排除在狨猴成纤维细胞中传代的ST - FeSV或SM - FeSV表面抗原发生了改变。FeSV在狨猴细胞传代过程中相对感染性的改变可能是由于:(1)从原始异质未克隆群体中选择了一种变体;(2)突变;或(3)与某些狨猴遗传物质发生重组,可能是一种尚未鉴定的内源性狨猴病毒。